This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
NZ PHARMAC to fund gefitinib for NSCLC. Pharmacoecon. Outcomes News 658, 11 (2012). https://doi.org/10.2165/00151234-201206580-00035
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206580-00035